Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously
NCT03450447 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-03-01
Summary
To summarise the outcomes of a treatment decision of patients with superficial esophageal carcinoma synchronously associated with head and neck cancer, that is endoscopic treatment for the superficial esophageal carcinoma plus surgery of the head and neck carcinoma.
Conditions
- Head and Neck Cancer
- Esophageal Cancer Stage
Sponsors & Collaborators
-
Yanqing Li
lead OTHER
Principal Investigators
-
Yanqing Li · Department of Gastroenterology, Qilu Hospital, Shandong University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-10
- Primary Completion
- 2020-02-07
- Completion
- 2020-05-07
Countries
- China
Study Locations
More Related Trials
-
A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma
NCT05432219 ·Status: UNKNOWN ·Phase: NA
-
Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma
NCT02908204 ·Status: UNKNOWN
-
Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?
NCT00583934 ·Status: COMPLETED
-
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 ·Status: RECRUITING ·Phase: NA
-
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma
NCT03404921 ·Status: COMPLETED ·Phase: NA
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
NCT05570487 ·Status: UNKNOWN
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis
NCT05812495 ·Status: UNKNOWN ·Phase: NA
-
The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC)
NCT06828718 ·Status: ACTIVE_NOT_RECRUITING
-
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT01216527 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
NCT01089803 ·Status: COMPLETED
-
Endoscopy Screening for Esophageal Cancer
NCT00927446 ·Status: TERMINATED
-
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
NCT05937438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT06889402 ·Status: NOT_YET_RECRUITING
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
Laparoscopic Versus Open Lower Mediastinal Lymphadenectomy for Esophagogastric Junction Cancer
NCT04443478 ·Status: RECRUITING
-
The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer
NCT04074447 ·Status: UNKNOWN
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy
NCT01973725 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
NCT03211377 ·Status: UNKNOWN
-
Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer
NCT05349045 ·Status: UNKNOWN
-
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
NCT05350891 ·Status: RECRUITING ·Phase: PHASE2